
Elinzanetant Shows Promise for Menopausal Symptom Relief
Elinzanetant, a novel, nonhormonal, selective dual neurokinin-1 (NK-1) and NK-3 receptor antagonist, may more effectively relieve vasomotor symptoms (VMS), also known as hot flashes, and sleep disturbances associated with menopause compared with other …